Markus Renschler
2020
In 2020, Markus Renschler earned a total compensation of $736.1K as President and Chief Executive Officer at Cyteir Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $180,000 |
|---|---|
| Option Awards | $106,116 |
| Salary | $450,000 |
| Total | $736,116 |
Renschler received $450K in salary, accounting for 61% of the total pay in 2020.
Renschler also received $180K in non-equity incentive plan and $106.1K in option awards.
Rankings
In 2020, Markus Renschler's compensation ranked 9,802nd out of 13,090 executives tracked by ExecPay. In other words, Renschler earned more than 25.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,802 out of 13,090 | 25th |
Division Manufacturing | 4,212 out of 5,624 | 25th |
Major group Chemicals And Allied Products | 1,727 out of 2,257 | 24th |
Industry group Drugs | 1,514 out of 1,957 | 23rd |
Industry Pharmaceutical Preparations | 1,117 out of 1,462 | 24th |
Source: SEC filing on April 29, 2022.
Renschler's colleagues
We found two more compensation records of executives who worked with Markus Renschler at Cyteir Therapeutics in 2020.